Names, Facts, Figures about Bayer Global
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care. Our research and development activities are therefore focused on improving people’s quality of life by preventing, alleviating and treating diseases. At the same time, we are making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials. Our understanding of the biochemical processes in living organisms helps us address these demanding challenges.
Our goal is to achieve and maintain leadership positions in our markets. In this way we create value for our customers, stockholders and employees, at the same time strengthening the company’s earning power.
We are committed to operating sustainably and addressing our social and ethical responsibilities. We also respect the interests of all our stakeholders. Employees with a passion for innovation enjoy excellent development opportunities at Bayer.
Following the stock market flotation of Covestro, we reorganized the Bayer Group effective January 1, 2016, and are now focusing on our Life Science activities. These businesses hold leading positions in innovation-driven, rapidly growing markets.
Together, the Life Science businesses make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks. Our operations are managed in three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit, which are also reporting segments.
Structure of the Bayer Group
Bayer still holds about 53% of Covestro AG. Covestro therefore also remains a fully consolidated reporting segment. The operational business is supported by the corporate functions – including Technology Services, which was integrated into Bayer AG effective July 1, 2016 – Business Services and the service company Currenta.
Business Operations Are the Responsibility of the Divisions
The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health Division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories.
The Crop Science Division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture. The Environmental Science operating unit provides products and services for professional nonagricultural applications, such as vector and pest control and forestry.
The Animal Health business unit ranks among the leading international innovators in its field. It develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.
Central Service Functions
The corporate functions and Business Services operate as Group-wide competence centers in which business support services are bundled.
Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.
Covestro* is one of the world’s leading suppliers of high-tech polymer materials and develops innovative product solutions for a wide variety of everyday uses.
Dual governance system with the following governance bodies:
seven members, Chairman: Werner Baumann
20 members, Chairman: Werner Wenning
With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.
Bayer’s extensive product portfolio contains numerous globally renowned brands.
Best-selling Bayer products are:
- in the Pharmaceuticals field: Xarelto™, Eylea™, Kogenate™, the Mirena™ product family, Nexavar™ and Betaferon™/Betaseron™
- in the Consumer Health field: Claritin™, Aspirin™, Aleve™, Bepanthen™ / Bepanthol™, Canesten™ and the Alka Seltzer™ product family
- the key brands in the agriculture field are: Confidor™ / Gaucho™, the Nativo™ product family, Nunhems™, Basta™/ Liberty™ and the Prosaro™ product family
- in the Animal Health field: the Advantage™ product family, Seresto™, the Drontal™ product family and Baytril™
The Bayer Group comprises around 301 consolidated companies** in 78 countries throughout the world. Global headquarters are in Leverkusen, Germany.
** fully consolidated subsidiaries (as of Dec. 31, 2016)
On December 31, 2016, the Bayer Group had 115,200 employees worldwide.
Employees by Region and Gender in 2016
|€ million||€ million||%|
|EBIT before special items2||7,060||8,130||+15.2|
|EBITDA before special items2||10,256||11,302||+10.2|
|EBITDA margin before special items4||22.3%||24.2%|
|Income before income taxes||5,236||5,887||+12.4|
|Earnings per share (€)5||4.97||5.44||+9.5|
|Core earnings per share (€)6||6.82||7.32||+7.3|
|Net financial debt||17,449||11,778||-32.5|
|Capital expenditures as per segment table||2,511||2,578||+2.7|
|Research and development expenses||4,274||4,666||+9.2|
|Dividend per Bayer AG share (€)||2.50||2.70||+8.0|
(as of Dec. 31, 2016)
formerly Bayer MaterialScience more